Forschung & Innovation
Publikationen
Durvalumab Prolongs Overall Survival, Whereas Radiation Dose Escalation > 66 Gy Might Improve Long-Term Local Control in Unresectable NSCLC Stage III: Updated Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)
PMU Autor*innen
Franz Zehentmayr, Elvis Ruznic, Brane Grambozov, Alexandra Hochreiter, Falk Röder
Alle Autor*innen
Franz Zehentmayr, Elvis Ruznic, Petra Feurstein, Brigitte Langer, Brane Grambozov, Marisa Klebermass, Alexandra Hochreiter, Ayurzana Purevdorj, Georg Gruber, Danijela Minasch, Barbara Böhmer-Breitfelder, Claudia Steffal, Karoline Kirchhammer, Heidi Stranzl, Falk Röder, Karin Dieckmann
Fachzeitschrift
Cancers